|
[1] WREE A,HOLTMANN TM,INZAUGARAT ME,et al. Novel drivers of the inflammatory response in liver injury and fibrosis[J]. Semin Liver Dis,2019,39(3):275-282.
|
|
[2] CHEN Q,SHI P,WANG Y,et al. GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity[J]. J Mol Cell Biol,2019,11(6):496-508.
|
|
[3] HUANG X,FENG Y,XIONG G,et al. Caspase-11,a specific sensor for intracellular lipopolysaccharide recognition,mediates the non-canonical inflammatory pathway of pyroptosis[J]. Cell Biosci,2019,9:31.
|
|
[4] AMARANTE-MENDES GP,ADJEMIAN S,BRANCO LM,et al. Pattern recognition receptors and the host cell death molecular machinery[J]. Front Immunol,2018,9:2379.
|
|
[5] MAN S,KARKI R,KANNEGANTI T. Molecular mechanisms and functions of pyroptosis,inflammatory caspases and inflammasomes in infectious diseases[J]. Immunol Rev,2017,277(1):61-75.
|
|
[6] HE Y,HARA H,NU'EZ G. Mechanism and regulation of NLRP3 inflammasome activation[J]. Trends Biochem Sci,2016,41(12):1012-1021.
|
|
[7] XIA X,WANG X,ZHENG Y,et al. What role does pyroptosis play in microbial infection?[J]. J Cell Physiol,2019,234(6):7885-7892.
|
|
[8] KAYAGAKI N,WARMING S,LAMKANFI M,et al. Non-canonical inflammasome activation targets caspase-11[J]. Nature,2011,479(7371):117-121.
|
|
[9] HE YUAN,HARA HIDEKI,NUNEZ G. Mechanism and regulation of NLRP3 inflammasome activation[J]. Trends Biochem Sci,2016,41:1012-1021.
|
|
[10] SAVIO L,de ANDRADE MELLO P,DA SILVA CG,et al. The P2X7 receptor in inflammatory diseases:Angel or demon?[J]. Front Pharmacol,2018,9:52.
|
|
[11] DING J,SHAO F. Growing a gasdermin pore in membranes of pyroptotic cells[J]. EMBO J,2018,37(15):e100067.
|
|
[12] YANG D,HE Y,MUN¨OZ-PLANILLO R,et al. Caspase-11requires the pannexin-1 channel and the purinergic P2X7pore to mediate pyroptosis and endotoxic shock[J]. Immunity,2015,43(5):923-932.
|
|
[13] WANG Y,GAO W,SHI X,et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J].Nature,2017,547(7661):99-103.
|
|
[14] KHANOVA E,WU R,WANG W,et al. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients[J]. Hepatology,2018,67(5):1737-1753.
|
|
[15] CUI K,YAN G,XU C,et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1βin mice[J]. J Hepatol,2015,62(6):1311-1318.
|
|
[16] HEO MJ,KIM TH,YOU JS,et al. Alcohol dysregulates miR-148a in hepatocytes through Fox O1,facilitating pyroptosis via TXNIP overexpression[J]. Gut,2019,68(4):708-720.
|
|
[17] SHI C,XUE W,HAN B,et al. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/m TOR pathway[J]. Eur J Pharmacol,2019,850:15-22.
|
|
[18] LV Y,GAO X,LUO Y,et al. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways[J]. J Nutr Biochem,2019,71:110-121.
|
|
[19] MITSUYOSHI H,YASUI K,HARA T,et al. Hepatic nucleotide binding oligomerization domain-like receptors pyrin domaincontaining 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease[J]. Hepatol Res,2017,47(13):1459-1468.
|
|
[20] ZHENG T,YANG X,LI W,et al. Salidroside attenuates highfat diet-induced nonalcoholic fatty liver disease via AMPKdependent TXNIP/NLRP3 pathway[J]. Oxid Med Cell Longev,2018,2018:8597897.
|
|
[21] MOLYVDAS A,GEORGOPOULOU U,LAZARIDIS N,et al. The role of the NLRP3 inflammasome and the activation of IL-1βin the pathogenesis of chronic viral hepatic inflammation[J]. Cytokine,2018,110:389-396.
|
|
[22] LUAN J,JU D. Inflammasome:A double-edged sword in liver diseases[J]. Front Immunol,2018,9:2201.
|
|
[23] INZAUGARAT ME,JOHNSON CD,HOLTMANN TM,et al. NLR family pyrin domain-containing 3 inflammasome activation in hepatic stel ate cells induces liver fibrosis in mice[J]. Hepatology,2019,69(2):845-859.
|
|
[24] MRIDHA AR,WREE A,ROBERTSON A,et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice[J]. J Hepatol,2017,66(5):1037-1046.
|
|
[25] YOU Y,HUANG Y,WANG D,et al. Angiotensin(1-7)inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation[J]. J Cell Physiol,2019,234(4):4668-4680.
|
|
[26] ZHENG H,WANG X,ZHANG Y,et al. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis[J]. J Ethnopharmacol,2019,244:111856.
|
|
[27] XIA X,WANG X,CHENG Z,et al. The role of pyroptosis in cancer:Pro-cancer or pro-“host”?[J]. Cell Death Dis,2019,10(9):650.
|
|
[28] WEI Q,ZHU R,ZHU J,et al. E2-induced activation of the NLRP3 inflammasome triggers pyroptosis and inhibits autophagy in HCC cells[J]. Oncol Res,2019,27(7):827-834.
|
|
[29] MA X,GUO P,QIU Y,et al. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of m TOR-S6K1 pathway[J]. Oncotarget,2016,7(24):36185-36197.
|
DownLoad: